The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for tozinameran and famtozinameran (Pfizer Australia Pty Ltd)
Active ingredients
tozinameran and famtozinameran
Sponsor
Date of review outcome
Lapse date
Type
Provisional determination
Indication
Booster for active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2
Therapeutic area
Infectious diseases